Skip to main content
RecallFDAfda-F-0046-2017UNDECLARED ALLERGEN

Enlightened Peanut Butter Chocolate Chip Ice Cream, one pint

Category
Units Affected
125
Recall Date
August 5, 2016
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0046-2017.

Select cases from a single production run of Enlightened brand Peanut Butter Chocolate Chip ice cream is being recalled because they may have been packaged in Mint Chocolate Chip ice cream containers and thus contain undeclared peanuts.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0046-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Cedar Crest Specialties, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0046-2017.

Cedar Crest Specialties, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Cedar Crest Specialties, Inc. Recall FAQ

Cedar Crest Specialties, Inc. is the subject of a dairy safety report: Enlightened Peanut Butter Chocolate Chip Ice Cream, one pint. The notice was published on August 5, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 125 units are potentially affected.